TuisSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Vorige sluiting
$3,85
Dagwisseling
$3,50 - $4,01
Jaarwisseling
$2,34 - $9,30
Markkapitalisasie
3,05 m USD
Gemiddelde volume
36,10 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 284,00 k | — |
Bedryfskoste | 1,86 m | -28,21% |
Netto inkomste | -2,32 m | 38,28% |
Netto winsgrens | -817,61 | — |
Wins per aandeel | — | — |
EBITDA | -1,53 m | 37,46% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,08 m | -59,02% |
Totale bates | 14,85 m | -25,36% |
Totale aanspreeklikheid | 22,14 m | -18,05% |
Totale ekwiteit | -7,28 m | — |
Uitstaande aandele | 837,36 k | — |
Prys om te bespreek | -0,44 | — |
Opbrengs op bates | -31,77% | — |
Opbrengs op kapitaal | -34,88% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -2,32 m | 38,28% |
Kontant van bedrywe | -1,76 m | 38,87% |
Kontant van beleggings | -6,00 k | 98,41% |
Kontant van finansiering | 12,00 k | — |
Netto kontantverandering | -1,87 m | 43,14% |
Beskikbare kontantvloei | -1,20 m | 60,77% |
Meer oor
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Gestig
01 Jan. 2003
Webwerf
Werknemers
31
